5257 |
Drug Coated Balloons: Present Status and Future of the Technology |
Aloke V. Finn |
Apr. 12. 21 |
5256 |
Orbital or Laser Atherectomy in Complex PCI |
Kevin Croce |
Apr. 12. 21 |
5255 |
What Is Complex PCI, Do Outcomes Depend on Complexity Type and Number? |
Mamas Mamas |
Apr. 12. 21 |
5254 |
Vulnerable Plaque: What Is It? Pathological Perspective |
Renu Virmani |
Apr. 12. 21 |
5253 |
Antiplatelets Only Sufficient: TAVR Antithrombotics Less is More |
George D. Dangas |
Apr. 12. 21 |
5252 |
Choice of PCI vs. CABG When Revascularization Is Indicated for LM Disease: CABG Preferred |
David Paul Taggart |
Apr. 12. 21 |
5251 |
Moderators\' Introductory Keynote: Why This Debate So Controversial? |
David R. Holmes |
Apr. 12. 21 |
5250 |
Transcatheter Mitral Valve Repair: Guideline Changes, Evidence Gaps and Future Directions |
Gregg W. Stone |
Apr. 12. 21 |
5249 |
TAVR Long Journey: Chain of RCTs, Guideline Changes, and Future Directions |
Martin Bert Leon |
Apr. 12. 21 |
5248 |
Update on Antithrombotic Therapy After ACS/PCI: Recent Advances and Innovations in Drugs and Strategy |
Deepak Bhatt |
Apr. 12. 21 |